【摘 要】
：
The vacuum induction brazing of SiC particulate reinforced LY12 alloy matrix composite using Al-28Cu-5Si-2Mg filler metal has been carried out. The micrograph o
论文部分内容阅读
The vacuum induction brazing of SiC particulate reinforced LY12 alloy matrix composite using Al-28Cu-5Si-2Mg filler metal has been carried out. The micrograph of the joint interface was observed by scanning electron microscopy. The joint strength was determined by shear tests. The results show that brazing temperature, holding time, SiC particle volume percentage and post heat treatment influence joint strength. SiC particles happen in the brazing seam and the distribution of SiC particles in the joint is not uniform. Particle-poor zones in the joint exist near the base metal, and particle concentrate zones exist in the center of the brazing seam. In addition, the failure of the composite is predominantly initiated by the rooting of SiC particle in the brazing seam and the micro-crack expanded along the brazing seam with low energy.
其他文献
目的总结淋巴瘤样肉芽肿病(lymphomatoid granulomatosis,LG)与韦格内肉芽肿(Wegener granulomatosis,WG)的临床特点,从临床上加以鉴别.方法回顾性总结我院与北京协和医院198
目的了解社交恐怖症患者的个性特征,为临床心理干预提供依据.方法采用明尼苏达多项个性调查表(MMPI),对40例社交恐怖症患者进行评定,与国内常模比较.结果男性的L、F、K、D、H
第五届亚太地区手外科学术大会,有关上肢周围神经外科交流论文95篇,主要涉及成人臂丛损伤、产瘫麻痹、上肢其它神经损伤、腕管综合征及周围神经基础研究等方面.对于成人臂丛
目的:探讨精神病人社区防治护理方法,促使社区精神病人尽快康复,重返社会.方法:采取防治结合,配合各种各样的社区康复护理.结果:经过一年多的社区防治护理后,3315例患者中,好
目的:探讨抗β2糖蛋白I抗体(aβ2GPI)检测在自身免疫病(AID)诊治中的意义. 方法:用ELISA法半定量检测抗核抗体(ANA)阳性患者、抗心磷脂抗体(ACA)阳性患者以及体检健康人血清
目的为克服普通钢板导致的应力遮挡我们设计了一种新型自动生理加压钢板,并测定其生物力学稳定性.方法采用成年防腐股骨标本30个,模拟股骨横断骨折,配对分成对照组、试验组,
目的建立和应用麻疹野病毒基因型快速诊断方法,及时监测麻疹流行株基因型动态,尽早发现异型输入病例.方法应用一种适用于我国现流行麻疹野病毒的基因型别筛查、定型的分析方
Active networks are a new kind of packet-switched networks in which packets have code fragments that are executed on the intermediary nodes (routers). The code
Objective: To observe the clinical therapeutic effect and side effect of pressure-control ventilation (PCV) on traumatic acute respiratory distress syndrome (AR
[目的]观察维生素K滴剂-Orakay(凯欧凯)口服对改善新生儿的维生素K营养状况的结果.[方法]将84例新生儿分为试验组59例(出生后口服Orakay 1 mg)和对照组25例(未用Orakay),于6～7